Triclosan and antibiotic resistance in Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue 1, 2000, Pages 11-18

  Suller, M T E ^a   Russell, A D ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; CETYLPYRIDINIUM SALT; CHLORAMPHENICOL; CHLORHEXIDINE ACETATE; DIBROMPROPAMIDINE ISETIONATE; DISINFECTANT AGENT; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; METICILLIN; NOVOBIOCIN; PENICILLIN G; PLASTIC; POTASSIUM; PSEUDOMONIC ACID; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; TRICLOCARBAN; TRICLOSAN; VANCOMYCIN; TOPICAL ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONTROLLED STUDY; EPIDEMIC; ESCHERICHIA COLI; HYGIENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; DRUG EFFECT; METABOLISM; MICROBIOLOGICAL EXAMINATION; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS, LOCAL; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; POTASSIUM; STAPHYLOCOCCUS AUREUS; TRICLOSAN;

EID: 0033941656     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/46.1.11     Document Type: Article

References (27)

1. Fraise, A. P. (1998). Topical treatment for eradication of MRSA. CME Bulletin Medical Microbiology 2, 10-1.
2. Levy, C. W., Roujeinikova, A., Sedelnikova, S., Baker, P. J., Stuitje, A. R., Slabas, A. R. et al. (1999). Molecular basis of triclosan activity. Nature 398, 384-5.
3. Duckworth, G. (1998). Report of a combined working party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. Journal of Hospital Infection 39, 253-90.
4. Zafar, A. B., Butler, R. C., Reese, D. J., Gaydos, L. A. & Mennonna, P. A. (1995). Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. American Journal of Infection Control 23, 200-8.
5. Brady, L. M., Thomson, M., Palmer, M. A. & Harkness, J. L. (1990). Successful control of endemic MRSA in a cardiothoracic surgical unit. Medical Journal of Australia 152, 240-5.
6. Webster, J., Faoagali, J. L. & Cartwright, D. (1994). Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan. Journal of Paediatrics and Child Health 30, 59-64.
7. Cookson, B. D., Farrelly, H., Stapleton, P., Garvey, R. P. J. & Price, M. R. (1991). Transferable resistance to triclosan in MRSA. Lancet 337, 1548-9.
8. Bamber, A. I. & Neal, T. J. (1999). An assessment of triclosan susceptibility in methicillin-resistant and methicillin-sensitive Staphylococcus aureus. Journal of Hospital Infection 41, 107-9.
9. Russell, A. D. (1997). Plasmids and bacterial resistance to biocides. Journal of Applied Microbiology 83, 155-65.
10. McMurry, L. M., Oethinger, M. & Levy, S. B. (1998). Triclosan targets lipid synthesis. Nature 394, 531-2.
11. McDonnell, G. & Pretzer, D. (1998). Action and targets of triclosan. ASM News 64, 670-1.
12. Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D, 1-50.
13. Tuffnell, D. J., Croton, R. S., Hemingway, D. M., Hartley, M. N., Wake, P. M. & Garvey, R. J. (1987). Methicillin resistant Staphylococcus aureus; the role of antisepsis in the control of an outbreak. Journal of Hospital Infection 10, 255-9.
14. Report of a Combined Working Party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy. (1990). Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. Journal of Hospital Infection 16, 351-77.
15. Suller, M. T. & Russell, A. D. (1999). Antibiotic and biocide resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Journal of Hospital Infection 43, 281-91.
16. Reverdy, M. E., Bes, M., Nervi, C., Martra, A. & Fleurette, J. (1992). Activity of four antiseptics (acriflavine, benzalkonium chloride, chlorhexidine digluconate and hexamidine di-isethionate) and of ethidium bromide on 392 strains representing 26 Staphylococcus species. Medical Microbiology Letters 1, 56-63.
17. Cox, A. R. (1987). Efficacy of the antimicrobial agent triclosan in topical deodorant products: Recent developments in vivo. Journal of the Society of Cosmetic Chemists 38, 223-31.
18. Heath, R. J., Yu, Y. T., Shapiro, M. A., Olson, E. & Rock, C. O. (1998). Broad spectrum antimicrobial biocides target the Fabl component of fatty acid synthesis. Journal of Biological Chemistry 273, 30316-20.
19. McMurry, L. M., McDermott, P. F. & Levy, S. B. (1999). Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrobial Agents and Chemotherapy 43, 711-3.
20. Larkin, M. (1999). A close look at triclosan raises questions. Lancet 353, 1160.
21. Cookson, B. D. (1994). Antiseptic resistance in methicillin-resistant Staphylococcus aureus: an emerging problem? Staphylococci and staphylococcal infections. In Proceedings of the Seventh International Symposium, Stockholm, 1994, pp. 227-34. Gustav Fischer, Stuttgart.
22. Farrelly, H. D., Stapleton, P., Garvey, R. P., Price, M. R. & Cookson, B. D. (1992). Transferable triclosan resistance in methicillin resistant Staphylococcus aureus. In 'Clinical Microbiology New Perspectives', Joint Meeting of the Association of Medical Microbiology, British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Irish Society of Clinical Microbiology, Dublin, 1992, abstract 41.
23. Russell, A. D., Suller, M. T. & Maillard, J. Y. (1999). Do antiseptics and disinfectants select for antibiotic resistance? Journal of Medical Microbiology 48, 613-5.
24. McMurry, L. M., Oethinger, M. & Levy, S. B. (1998). Over-expression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiology Letters 166, 305-9.
25. Schweizer, H. P. (1998). Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems. Antimicrobial Agents and Chemotherapy 42, 394-8.
26. Meincke, B. E., Kranz, R. G. & Lynch, D. L. (1980). Effect of irgasan on bacterial growth and its adsorption into the cell wall. Microbios 28, 133-47.
27. Russell, A. D. & McDonnell, G. (2000). Concentration: a major factor in studying biocidal action. Journal of Hospital Infection 44, 11-3.